Company intelligence / Profile preview

Quanttrace

Ownership: Private
Development stage: Preclinical

Overview

Quanttrace develops a wearable, non-invasive device that enables real-time therapeutic drug monitoring without disrupting patients' daily lives. The technology is designed to personalize healthcare by providing immediate plasma concentration measurements for drugs with narrow therapeutic windows. Data is processed via a mobile device and does not require laboratory equipment. This approach aims to optimize dosing and improve outcomes in personalized medicine.

Therapeutic areas: OtherOncologyNeurologyInfectious Diseases
Modalities: Non-invasive therapeutic drug monitoring devicesWearable health technology
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Quanttrace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quanttrace.

Explore the full profile